Differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with complements C3 and C4 and C-reactive protein

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1271-1276

  Li, Wenhui ^a   Li, Hui ^a   Song, Wuqi ^a   Hu, Yunlong ^a   Liu, Yanhong ^b   Da, Rong ^a   Chen, Xiaobei ^a   Li, Yang ^b   Ling, Hong ^a   Zhong, Zhaohua ^a   Zhang, Fengmin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

C reactive protein; Complement C3; Complement C4; Differential diagnosis; Disease activity; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RHEUMATOID ARTHRITIS; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

EID: 84884753419     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1304     Document Type: Article

References (23)

1. Rodríguez-Carrio J, Prado C, de Paz B, et al: Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients. Rheumatology (Oxford) 51: 1775-1784, 2012.
2. Shi YH, Li R, Chen S, Su Y and Jia Y: Analysis of clinical features and the outcome in 91 cases of mixed connective tissue diseases. Beijing Da Xue Xue Bao 44: 270-274, 2012 (In Chinese).
3. Turgeman Y, Atar S, Suleiman K, et al: Diagnostic and therapeutic percutaneous cardiac interventions without on-site surgical backup-review of 11 years experience. Isr Med Assoc J 5: 89-93, 2003.
4. Li H, Song W, Li Y, et al: Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29: 413-417, 2010.
5. Goldring SR: Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 42 (Suppl 2): ii11-ii16, 2003.
6. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythe-matosus. Arthritis Rheum 40: 1725, 1997.
7. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH et al: Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35: 630-640, 1992.
8. Gladman DD, Urowitz MB, Kagal A and Hallett D: Accurately describing changes in disease activity in Systemic Lupus Erythematosus. J Rheumatol 27: 377-379, 2000.
9. DA S-Score: http://www.das-score.nl/das28/en/difference-between-the-das-and-das28/importance-of-das28-and-tight-control/eular-response-criteria.html. Accessed May 3, 2013.
10. Ahmed TA, Ikram N, Hussain T, et al: Clinical and laboratory features of systemic lupus erythematosus (SLE) in Pakistani patients. J Pak Med Assoc 52: 12-15, 2002.
11. Pisetsky DS, Ullal AJ, Gauley J and Ning TC: Microparticles as mediators and biomarkers of rheumatic disease. Rheumatology (Oxford) 51: 1737-1746, 2012.
12. Wang H, Peng W, Ouyang X, Li W and Dai Y: Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res 160: 198-206, 2012.
13. Almeida Mdo S, Bértolo MB, Da Silva BB, De Deus Filho A, Almeida MM, Veras FF and Mendes LC: Epidemiological study of patients with connective tissue diseases in Brazil. Trop Doct 35: 206-209, 2005.
14. Patel RM and Marfatia YS: Lupus panniculitis as an initial manifestation of systemic lupus erythematosus. Indian J Dermatol 55: 99-101, 2010.
15. Molenaar ET, Voskuyl AE, Familian A, van Mierlo GJ, Dijkmans BA and Hack CE: Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum 44: 997-1002, 2001.
16. Chou CT and Hwang CM: Changes in the clinical and laboratory features of lupus patients after the big earthquake in Taiwan. Lupus 11: 109-113, 2002.
17. Lee SS, Singh S, Link K and Petri M: High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. Semin Arthritis Rheum 38: 41-54, 2008.
18. Yildiz M: Arterial distensibility in chronic inflammatory rheumatic disorders. Open Cardiovasc Med J 4: 83-88, 2010.
19. Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC and Jessop JD: Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 43: 1473-1477, 2000.
20. Gonnet-Gracia C, Barnetche T, Richez C, et al: Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers. Clin Exp Rheumatol 26: 401-407, 2008.
21. Petri M, Purvey S, Fang H and Magder LS: Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort. Arthritis Rheum 64: 4021-4028, 2012.
22. Hoff M, Bøyesen P, Haugeberg G, et al: High disease activity is a predictor of cortical hand bone loss in post-menopausal patients with established rheumatoid arthritis: a 5-year multicentre longitudinal study. Rheumatology (Oxford) 49: 1676-1682, 2010.
23. Kawashiri SY, Kawakami A, Okada A, et al: CD4+CD25(high) CD127(low/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J Rheumatol 38: 2517-2521, 2011.